APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cryptococcosis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cryptococcosis Market Outlook and Growth Opportunities 2026

Report ID 173981630420 December 2025194 pages

Choose your research edition.

Industry ResearchCryptococcosis Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Cryptococcosis Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Cryptococcosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cryptococcosis Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Cryptococcosis Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cryptococcosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cryptococcosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cryptococcosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cryptococcosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cryptococcosis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cryptococcosis market include Bausch Health, Bristol-Myers Squibb, Glenmark, Sigmapharm, Viamet Pharmaceuticals, Pfizer, Novartis, Johnson & Johnson and Abbott, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cryptococcosis market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cryptococcosis and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cryptococcosis sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cryptococcosis market size, projected growth trends, production technologies, key applications, and end-use industries.

Cryptococcosis Segment by Company

Bausch Health

Bristol-Myers Squibb

Glenmark

Sigmapharm

Viamet Pharmaceuticals

Pfizer

Novartis

Johnson & Johnson

Abbott

Cryptococcosis Segment by Type

Voriconazole

Flucytosine (Ancobon)

Fluconazole (Diflucan)

Amphotericin B (Amphocin and Fungizone)

Cryptococcosis Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Cryptococcosis Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Cryptococcosis status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cryptococcosis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cryptococcosis significant trends, drivers, influence factors in global and regions.

6. To analyze Cryptococcosis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cryptococcosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cryptococcosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cryptococcosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cryptococcosis market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cryptococcosis industry.

Chapter 3: Detailed analysis of Cryptococcosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cryptococcosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cryptococcosis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cryptococcosis Industry Trends Table 2. Cryptococcosis Industry Drivers Table 3. Cryptococcosis Industry Opportunities and Challenges Table 4. Cryptococcosis Industry Restraints Table 5. Global Cryptococcosis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cryptococcosis Revenue Share by Company (2021-2026) Table 7. Global Cryptococcosis Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Cryptococcosis Sales Volume Share by Company (2021-2026) Table 9. Global Cryptococcosis Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Cryptococcosis Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cryptococcosis Key Company Manufacturing Base & Headquarters Table 12. Global Cryptococcosis Company, Product Type & Application Table 13. Global Cryptococcosis Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cryptococcosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Voriconazole Table 18. Significant Companies of Flucytosine (Ancobon) Table 19. Significant Companies of Fluconazole (Diflucan) Table 20. Significant Companies of Amphotericin B (Amphocin and Fungizone) Table 21. Global Cryptococcosis Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 22. Global Cryptococcosis Sales Volume by Type (2021-2026) & (Kg) Table 23. Global Cryptococcosis Sales Volume by Type (2027-2032) & (Kg) Table 24. Global Cryptococcosis Sales Volume Share by Type (2021-2026) Table 25. Global Cryptococcosis Sales Volume Share by Type (2027-2032) Table 26. Global Cryptococcosis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cryptococcosis Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Cryptococcosis Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Cryptococcosis Sales Value Share by Type (2021-2026) Table 30. Global Cryptococcosis Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Retail Pharmacies Table 32. Significant Companies of Online Pharmacies Table 33. Significant Companies of Hospital Pharmacies Table 34. Global Cryptococcosis Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 35. Global Cryptococcosis Sales Volume by Application (2021-2026) & (Kg) Table 36. Global Cryptococcosis Sales Volume by Application (2027-2032) & (Kg) Table 37. Global Cryptococcosis Sales Volume Share by Application (2021-2026) Table 38. Global Cryptococcosis Sales Volume Share by Application (2027-2032) Table 39. Global Cryptococcosis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Cryptococcosis Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Cryptococcosis Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Cryptococcosis Sales Value Share by Application (2021-2026) Table 43. Global Cryptococcosis Sales Value Share by Application (2027-2032) Table 44. Global Cryptococcosis Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 45. Global Cryptococcosis Sales by Region (2021-2026) & (Kg) Table 46. Global Cryptococcosis Sales Market Share by Region (2021-2026) Table 47. Global Cryptococcosis Sales by Region (2027-2032) & (Kg) Table 48. Global Cryptococcosis Sales Market Share by Region (2027-2032) Table 49. Global Cryptococcosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Cryptococcosis Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Cryptococcosis Sales Value Share by Region (2021-2026) Table 52. Global Cryptococcosis Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Cryptococcosis Sales Value Share by Region (2027-2032) Table 54. Global Cryptococcosis Market Average Price (US$/Kg) by Region (2021-2026) Table 55. Global Cryptococcosis Market Average Price (US$/Kg) by Region (2027-2032) Table 56. Global Cryptococcosis Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 57. Global Cryptococcosis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Cryptococcosis Sales by Country (2021-2026) & (Kg) Table 59. Global Cryptococcosis Sales Market Share by Country (2021-2026) Table 60. Global Cryptococcosis Sales by Country (2027-2032) & (Kg) Table 61. Global Cryptococcosis Sales Market Share by Country (2027-2032) Table 62. Global Cryptococcosis Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Cryptococcosis Sales Value Market Share by Country (2021-2026) Table 64. Global Cryptococcosis Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Cryptococcosis Sales Value Market Share by Country (2027-2032) Table 66. Bausch Health Company Information Table 67. Bausch Health Business Overview Table 68. Bausch Health Cryptococcosis Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 69. Bausch Health Cryptococcosis Product Portfolio Table 70. Bausch Health Recent Development Table 71. Bristol-Myers Squibb Company Information Table 72. Bristol-Myers Squibb Business Overview Table 73. Bristol-Myers Squibb Cryptococcosis Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Bristol-Myers Squibb Cryptococcosis Product Portfolio Table 75. Bristol-Myers Squibb Recent Development Table 76. Glenmark Company Information Table 77. Glenmark Business Overview Table 78. Glenmark Cryptococcosis Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Glenmark Cryptococcosis Product Portfolio Table 80. Glenmark Recent Development Table 81. Sigmapharm Company Information Table 82. Sigmapharm Business Overview Table 83. Sigmapharm Cryptococcosis Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Sigmapharm Cryptococcosis Product Portfolio Table 85. Sigmapharm Recent Development Table 86. Viamet Pharmaceuticals Company Information Table 87. Viamet Pharmaceuticals Business Overview Table 88. Viamet Pharmaceuticals Cryptococcosis Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Viamet Pharmaceuticals Cryptococcosis Product Portfolio Table 90. Viamet Pharmaceuticals Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Cryptococcosis Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Pfizer Cryptococcosis Product Portfolio Table 95. Pfizer Recent Development Table 96. Novartis Company Information Table 97. Novartis Business Overview Table 98. Novartis Cryptococcosis Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. Novartis Cryptococcosis Product Portfolio Table 100. Novartis Recent Development Table 101. Johnson & Johnson Company Information Table 102. Johnson & Johnson Business Overview Table 103. Johnson & Johnson Cryptococcosis Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. Johnson & Johnson Cryptococcosis Product Portfolio Table 105. Johnson & Johnson Recent Development Table 106. Abbott Company Information Table 107. Abbott Business Overview Table 108. Abbott Cryptococcosis Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. Abbott Cryptococcosis Product Portfolio Table 110. Abbott Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Cryptococcosis Distributors List Table 114. Cryptococcosis Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Cryptococcosis Product Image Figure 2. Global Cryptococcosis Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cryptococcosis Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cryptococcosis Sales (2021-2032) & (Kg) Figure 5. Global Cryptococcosis Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Cryptococcosis Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Voriconazole Image Figure 10. Flucytosine (Ancobon) Image Figure 11. Fluconazole (Diflucan) Image Figure 12. Amphotericin B (Amphocin and Fungizone) Image Figure 13. Global Cryptococcosis Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global Cryptococcosis Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Cryptococcosis Sales Volume Share by Type (2021-2032) Figure 16. Global Cryptococcosis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cryptococcosis Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cryptococcosis Sales Value Share by Type (2021-2032) Figure 19. Retail Pharmacies Image Figure 20. Online Pharmacies Image Figure 21. Hospital Pharmacies Image Figure 22. Global Cryptococcosis Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 23. Global Cryptococcosis Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Cryptococcosis Sales Volume Share by Application (2021-2032) Figure 25. Global Cryptococcosis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Cryptococcosis Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Cryptococcosis Sales Value Share by Application (2021-2032) Figure 28. Global Cryptococcosis Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 29. Global Cryptococcosis Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Cryptococcosis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Cryptococcosis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Cryptococcosis Sales Value (2021-2032) & (US$ Million) Figure 33. North America Cryptococcosis Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Cryptococcosis Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Cryptococcosis Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Cryptococcosis Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Cryptococcosis Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Cryptococcosis Sales Value (2021-2032) & (US$ Million) Figure 39. South America Cryptococcosis Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Cryptococcosis Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Cryptococcosis Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Cryptococcosis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Cryptococcosis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Cryptococcosis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Cryptococcosis Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Cryptococcosis Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Voriconazole
  • Flucytosine (Ancobon)
  • Fluconazole (Diflucan)
  • Amphotericin B (Amphocin and Fungizone)
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Bausch Health
  • Bristol-Myers Squibb
  • Glenmark
  • Sigmapharm
  • Viamet Pharmaceuticals
  • Pfizer
  • Novartis
  • Johnson & Johnson
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cryptococcosis Sales Value (2021-2032)
  4. 1.2.2 Global Cryptococcosis Sales Volume (2021-2032)
  5. 1.2.3 Global Cryptococcosis Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cryptococcosis Market Dynamics
  1. 2.1 Cryptococcosis Industry Trends
  2. 2.2 Cryptococcosis Industry Drivers
  3. 2.3 Cryptococcosis Industry Opportunities and Challenges
  4. 2.4 Cryptococcosis Industry Restraints
3 Cryptococcosis Market by Company
  1. 3.1 Global Cryptococcosis Company Revenue Ranking in 2025
  2. 3.2 Global Cryptococcosis Revenue by Company (2021-2026)
  3. 3.3 Global Cryptococcosis Sales Volume by Company (2021-2026)
  4. 3.4 Global Cryptococcosis Average Price by Company (2021-2026)
  5. 3.5 Global Cryptococcosis Company Ranking (2024-2026)
  6. 3.6 Global Cryptococcosis Company Manufacturing Base and Headquarters
  7. 3.7 Global Cryptococcosis Company Product Type and Application
  8. 3.8 Global Cryptococcosis Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cryptococcosis Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cryptococcosis Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cryptococcosis Market by Type
  1. 4.1 Cryptococcosis Type Introduction
  2. 4.1.1 Voriconazole
  3. 4.1.2 Flucytosine (Ancobon)
  4. 4.1.3 Fluconazole (Diflucan)
  5. 4.1.4 Amphotericin B (Amphocin and Fungizone)
  6. 4.2 Global Cryptococcosis Sales Volume by Type
  7. 4.2.1 Global Cryptococcosis Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cryptococcosis Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Cryptococcosis Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Cryptococcosis Sales Value by Type
  11. 4.3.1 Global Cryptococcosis Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Cryptococcosis Sales Value by Type (2021-2032)
  13. 4.3.3 Global Cryptococcosis Sales Value Share by Type (2021-2032)
5 Cryptococcosis Market by Application
  1. 5.1 Cryptococcosis Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Cryptococcosis Sales Volume by Application
  6. 5.2.1 Global Cryptococcosis Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cryptococcosis Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Cryptococcosis Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Cryptococcosis Sales Value by Application
  10. 5.3.1 Global Cryptococcosis Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cryptococcosis Sales Value by Application (2021-2032)
  12. 5.3.3 Global Cryptococcosis Sales Value Share by Application (2021-2032)
6 Cryptococcosis Regional Sales and Value Analysis
  1. 6.1 Global Cryptococcosis Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cryptococcosis Sales by Region (2021-2032)
  3. 6.2.1 Global Cryptococcosis Sales by Region: 2021-2026
  4. 6.2.2 Global Cryptococcosis Sales by Region (2027-2032)
  5. 6.3 Global Cryptococcosis Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cryptococcosis Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cryptococcosis Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cryptococcosis Sales Value by Region (2027-2032)
  9. 6.5 Global Cryptococcosis Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cryptococcosis Sales Value (2021-2032)
  12. 6.6.2 North America Cryptococcosis Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cryptococcosis Sales Value (2021-2032)
  15. 6.7.2 Europe Cryptococcosis Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cryptococcosis Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cryptococcosis Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cryptococcosis Sales Value (2021-2032)
  21. 6.9.2 South America Cryptococcosis Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cryptococcosis Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cryptococcosis Sales Value Share by Country, 2025 VS 2032
7 Cryptococcosis Country-level Sales and Value Analysis
  1. 7.1 Global Cryptococcosis Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cryptococcosis Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cryptococcosis Sales by Country (2021-2032)
  4. 7.3.1 Global Cryptococcosis Sales by Country (2021-2026)
  5. 7.3.2 Global Cryptococcosis Sales by Country (2027-2032)
  6. 7.4 Global Cryptococcosis Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cryptococcosis Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cryptococcosis Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cryptococcosis Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cryptococcosis Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cryptococcosis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cryptococcosis Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cryptococcosis Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cryptococcosis Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cryptococcosis Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cryptococcosis Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cryptococcosis Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cryptococcosis Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cryptococcosis Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cryptococcosis Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cryptococcosis Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cryptococcosis Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cryptococcosis Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cryptococcosis Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cryptococcosis Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cryptococcosis Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cryptococcosis Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cryptococcosis Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cryptococcosis Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cryptococcosis Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cryptococcosis Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cryptococcosis Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cryptococcosis Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cryptococcosis Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cryptococcosis Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cryptococcosis Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cryptococcosis Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cryptococcosis Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cryptococcosis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bausch Health
  2. 8.1.1 Bausch Health Company Information
  3. 8.1.2 Bausch Health Business Overview
  4. 8.1.3 Bausch Health Cryptococcosis Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bausch Health Cryptococcosis Product Portfolio
  6. 8.1.5 Bausch Health Recent Developments
  7. 8.2 Bristol-Myers Squibb
  8. 8.2.1 Bristol-Myers Squibb Company Information
  9. 8.2.2 Bristol-Myers Squibb Business Overview
  10. 8.2.3 Bristol-Myers Squibb Cryptococcosis Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bristol-Myers Squibb Cryptococcosis Product Portfolio
  12. 8.2.5 Bristol-Myers Squibb Recent Developments
  13. 8.3 Glenmark
  14. 8.3.1 Glenmark Company Information
  15. 8.3.2 Glenmark Business Overview
  16. 8.3.3 Glenmark Cryptococcosis Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Glenmark Cryptococcosis Product Portfolio
  18. 8.3.5 Glenmark Recent Developments
  19. 8.4 Sigmapharm
  20. 8.4.1 Sigmapharm Company Information
  21. 8.4.2 Sigmapharm Business Overview
  22. 8.4.3 Sigmapharm Cryptococcosis Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sigmapharm Cryptococcosis Product Portfolio
  24. 8.4.5 Sigmapharm Recent Developments
  25. 8.5 Viamet Pharmaceuticals
  26. 8.5.1 Viamet Pharmaceuticals Company Information
  27. 8.5.2 Viamet Pharmaceuticals Business Overview
  28. 8.5.3 Viamet Pharmaceuticals Cryptococcosis Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Viamet Pharmaceuticals Cryptococcosis Product Portfolio
  30. 8.5.5 Viamet Pharmaceuticals Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Cryptococcosis Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Cryptococcosis Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Novartis
  38. 8.7.1 Novartis Company Information
  39. 8.7.2 Novartis Business Overview
  40. 8.7.3 Novartis Cryptococcosis Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Novartis Cryptococcosis Product Portfolio
  42. 8.7.5 Novartis Recent Developments
  43. 8.8 Johnson & Johnson
  44. 8.8.1 Johnson & Johnson Company Information
  45. 8.8.2 Johnson & Johnson Business Overview
  46. 8.8.3 Johnson & Johnson Cryptococcosis Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Johnson & Johnson Cryptococcosis Product Portfolio
  48. 8.8.5 Johnson & Johnson Recent Developments
  49. 8.9 Abbott
  50. 8.9.1 Abbott Company Information
  51. 8.9.2 Abbott Business Overview
  52. 8.9.3 Abbott Cryptococcosis Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Abbott Cryptococcosis Product Portfolio
  54. 8.9.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cryptococcosis Value Chain Analysis
  2. 9.1.1 Cryptococcosis Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cryptococcosis Sales Mode & Process
  6. 9.2 Cryptococcosis Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cryptococcosis Distributors
  9. 9.2.3 Cryptococcosis Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst